newsfilter
← Latest News
GlobeNewswire·

CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights

Strengthened balance sheet with private placement of up to $100 million to advance CMP-002, a first-in-class treatment for SYNGAP1-related disorders Initiated Good Laboratory Practice (GLP) toxicology studies for